Laird Norton Wetherby Wealth Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,570
Closed -$244K 958
2023
Q2
$244K Buy
+3,570
New +$230K 0.01% 782
2023
Q1
Sell
-3,840
Closed -$231K 942
2022
Q4
$231K Sell
3,840
-3,242
-46% -$190K 0.01% 759
2022
Q3
$429K Sell
7,082
-2,000
-22% -$63.2K 0.03% 543
2022
Q2
$247K Buy
9,082
+2,500
+38% +$73.1K 0.02% 748
2022
Q1
$241K Buy
+6,582
New +$237K 0.01% 790
2021
Q4
Sell
-3,906
Closed -$278K 953
2021
Q3
$278K Sell
3,906
-741
-16% -$46K 0.02% 743
2021
Q2
$239K Buy
+4,647
New +$145K 0.01% 797

Other funds holding PRTA

Laird Norton Wetherby Wealth Management's PRTA Position: Q3 2023 in Review

Laird Norton Wetherby Wealth Management sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 3,570 shares — an estimated $244K sold.

Laird Norton Wetherby Wealth Management first reported a position in PRTA in Q2 2021 and held it in 7 quarters. The position peaked at $429K in Q3 2022. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • Laird Norton Wetherby Wealth Management reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 3,570 Prothena Corp shares in Q3 2023, an estimated $244K.
  • Laird Norton Wetherby Wealth Management first reported a position in Prothena Corp in Q2 2021 and held it in 7 quarters.
  • Laird Norton Wetherby Wealth Management's Prothena Corp position peaked at $429K in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.